Disruptive Innovation in Clinical Trials: Tools to Accelerate Recruitment

4:00 PM - 5:00 PM, Monday, June 3,2019 ・ 104AB, Level 100
We have all heard the statistics - 19% of clinical trials terminate due to failed recruitment or complete with less than 85% of expected enrollment resulting in up to $8M in lost revenue to sponsors per day a trial is delayed. This panel will feature clinical research innovators focused on implementing novel approaches to long standing industry challenges. Panelists will take a deep dive into the numbers, using real-world case studies to quantify the value of early adoption of innovative approaches to clinical studies and the advantages of cohesive, operationally seamless models.
Moderator
photo
Director, R&D Information Head for Clinical Biologics
AstraZeneca
Speakers
photo
Director, Clinical Trials Business
23andMe, Inc.
photo
CEO/Co-Founder
Trialspark
photo
Senior Manager, Clinical Management
Otsuka Pharmaceutical Companies (U.S.)
photo
Director, R&D Information Head for Clinical Biologics
AstraZeneca